Froome case is a 'blow' to WADA's credibility – Usada head Travis Tygart

- Advertisement -

The handling of Chris Froome’s asthma drug case is a “blow” to the World Anti-Doping Agency’s credibility, says US Anti-Doping Agency head, Travis Tygart.
Froome was under investigation after more than the allowed level of the legal drug, salbutamol, was found in his urine.
Wada accepted that there was no breach and cycling’s world governing body, the UCI, dropped the case on 2 July after nine months.
Tygart told BBC Sport he believes there is a “lack of transparency” over that decision.
“The question is whether justice was truly served or did a star get an undeserved break,” he said.
“Unfortunately it’s another blow to the perceived credibility of the global anti-doping movement.”
Wada and the UCI have released some details of Froome’s case but Tygart, who led the investigation that saw former cyclist Lance Armstrong banned for life for doping, said without knowing exactly how the decision was reached, the case is “another shard that has damaged the credibility of WADA.”
Tygart added the lack of clarity was unfair to Froome, as it left the four-time Tour de France winner facing the “worst-case scenario” where he is “caught” between being seen as having benefitted from his high profile, even if his reputation has perhaps been “unfairly tarnished.” (BBC Sport)

- Advertisement -


Please enter your comment!
Please enter your name here